CareDx director Goldberg receives 588-share grant

CareDx, Inc. director Michael Goldberg acquired 588 shares of common stock on October 2, 2026, as an automatic quarterly grant in lieu of cash for non-employee director compensation under the issuer’s Outside Director Compensation Policy.

Rhea-AI Filing Summary

CareDx, Inc. director Michael Goldberg acquired 588 shares of common stock on October 2, 2026, as an automatic quarterly grant in lieu of cash for non-employee director compensation under the issuer’s Outside Director Compensation Policy. After the grant, Goldberg directly held 62,326 shares. The Cavallo Trust held 91,045 shares; Goldberg and his spouse are trustees.

Insider Trade Summary

Grant/Award: 588 shares

Grant/Award 2 txns

Insider Goldberg Michael

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	588	$0.00	$0.00
holding	Common Stock F2	--	--	--

Holdings After Transaction: Common Stock — 62,326 shares (Direct); Common Stock — 91,045 shares (Indirect, See Footnote)

Footnotes (2)

1. F1. Represents an automatic quarterly grant of common stock to the Reporting Person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.
2. F2. Represents shares held by the Cavallo Trust of which the Reporting Person and the Reporting Person's spouse are trustees.

Key Figures

Shares granted: 588 shares Reported price per share: $0.0000 per share Direct shares held after grant: 62,326 shares +1 more

4 metrics

Shares granted 588 shares Common stock grant on October 2, 2026

Reported price per share $0.0000 per share Common stock grant on October 2, 2026

Direct shares held after grant 62,326 shares Michael Goldberg’s reported direct holdings on October 2, 2026

Cavallo Trust shares 91,045 shares Shares held by the Cavallo Trust; Michael Goldberg and his spouse are trustees

Key Terms

automatic quarterly grant, in lieu of cash, Outside Director Compensation Policy

3 terms

automatic quarterly grant financial

"Represents an automatic quarterly grant of common stock"

in lieu of cash financial

"in lieu of cash for non-employee director compensation"

Outside Director Compensation Policy technical

"pursuant to the issuer's Outside Director Compensation Policy"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did CDNA director Michael Goldberg receive?

Michael Goldberg, a CareDx director, acquired 588 shares of common stock on October 2, 2026. The shares were an automatic quarterly grant in lieu of cash for non-employee director compensation under CareDx’s Outside Director Compensation Policy.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/05/2026 - 05:35 PM Accepted by SEC EDGAR 10/05/2026 - 05:35 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Goldberg Michael

(Last) (First) (Middle)

C/O CAREDX, INC.

8000 MARINA BOULEVARD, 4TH FLOOR

(Street)

BRISBANE CALIFORNIA 94005

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CareDx, Inc. [ CDNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/02/2026		A		588(1)	A	$0	62,326	D
Common Stock								91,045	I	See Footnote(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an automatic quarterly grant of common stock to the Reporting Person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

2. Represents shares held by the Cavallo Trust of which the Reporting Person and the Reporting Person's spouse are trustees.

	/s/ Jeffrey Adam Novack, Attorney-in-Fact	10/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)